Premier Path Wealth Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Premier Path Wealth Partners, LLC
- $587 Billion
- Q2 2024
A detailed history of Premier Path Wealth Partners, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 620 shares of REGN stock, worth $651,768. This represents 0.11% of its overall portfolio holdings.
Number of Shares
620
Previous 558
11.11%
Holding current value
$651,768
Previous $537 Million
21.34%
% of portfolio
0.11%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,463Shares Held
84.5MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$9.45 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$8.88 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$8.7 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.09 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.88 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $113B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...